Evotec (EVO) Competitors $3.44 +0.04 (+1.18%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$3.46 +0.02 (+0.58%) As of 09/3/2025 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock EVO vs. MRUS, CRSP, TGTX, CYTK, AAPG, KRYS, ACAD, ADMA, TLX, and PCVXShould you be buying Evotec stock or one of its competitors? The main competitors of Evotec include Merus (MRUS), CRISPR Therapeutics (CRSP), TG Therapeutics (TGTX), Cytokinetics (CYTK), Ascentage Pharma Group International (AAPG), Krystal Biotech (KRYS), ACADIA Pharmaceuticals (ACAD), ADMA Biologics (ADMA), Telix Pharmaceuticals (TLX), and Vaxcyte (PCVX). These companies are all part of the "pharmaceutical products" industry. Evotec vs. Its Competitors Merus CRISPR Therapeutics TG Therapeutics Cytokinetics Ascentage Pharma Group International Krystal Biotech ACADIA Pharmaceuticals ADMA Biologics Telix Pharmaceuticals Vaxcyte Merus (NASDAQ:MRUS) and Evotec (NASDAQ:EVO) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations. Does the media prefer MRUS or EVO? In the previous week, Merus had 9 more articles in the media than Evotec. MarketBeat recorded 10 mentions for Merus and 1 mentions for Evotec. Evotec's average media sentiment score of 1.76 beat Merus' score of 1.31 indicating that Evotec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merus 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Evotec 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is MRUS or EVO more profitable? Evotec has a net margin of -20.14% compared to Merus' net margin of -685.64%. Evotec's return on equity of -16.94% beat Merus' return on equity.Company Net Margins Return on Equity Return on Assets Merus-685.64% -50.28% -42.00% Evotec -20.14%-16.94%-8.14% Do analysts rate MRUS or EVO? Merus presently has a consensus price target of $88.75, indicating a potential upside of 33.22%. Evotec has a consensus price target of $5.40, indicating a potential upside of 56.98%. Given Evotec's higher probable upside, analysts plainly believe Evotec is more favorable than Merus.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Merus 0 Sell rating(s) 0 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.08Evotec 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do insiders and institutionals believe in MRUS or EVO? 96.1% of Merus shares are held by institutional investors. Comparatively, 5.8% of Evotec shares are held by institutional investors. 3.7% of Merus shares are held by insiders. Comparatively, 1.0% of Evotec shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings & valuation, MRUS or EVO? Evotec has higher revenue and earnings than Merus. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMerus$36.13M139.45-$215.33M-$5.50-12.11Evotec$777.33M1.57-$212.18MN/AN/A Which has more volatility & risk, MRUS or EVO? Merus has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, Evotec has a beta of 1.72, suggesting that its stock price is 72% more volatile than the S&P 500. SummaryEvotec beats Merus on 8 of the 15 factors compared between the two stocks. Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVO vs. The Competition Export to ExcelMetricEvotecMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.21B$2.51B$5.77B$9.76BDividend YieldN/A48.51%6.66%4.49%P/E RatioN/A22.6482.3726.60Price / Sales1.57709.32525.77170.66Price / CashN/A26.3325.7028.92Price / Book1.276.7910.646.56Net Income-$212.18M$32.94M$3.28B$266.04M7 Day Performance-1.99%0.80%0.09%-0.89%1 Month Performance-11.34%6.13%8.90%4.34%1 Year Performance4.24%-0.23%48.37%24.06% Evotec Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVOEvotec2.0029 of 5 stars$3.44+1.2%$5.40+57.0%-0.3%$1.21B$777.33M0.004,827Positive NewsAnalyst ForecastMRUSMerus2.9802 of 5 stars$65.74-2.6%$88.64+34.8%+32.0%$5.10B$36.13M-11.9537News CoveragePositive NewsCRSPCRISPR Therapeutics3.5926 of 5 stars$54.13-0.3%$71.60+32.3%+16.4%$4.94B$37.31M-9.97460Analyst RevisionTGTXTG Therapeutics4.4119 of 5 stars$28.53-3.1%$46.25+62.1%+40.2%$4.67B$329M77.11290News CoveragePositive NewsCYTKCytokinetics4.1069 of 5 stars$37.01-3.5%$71.58+93.4%-8.4%$4.59B$18.47M-7.26250Trending NewsAnalyst ForecastInsider TradeOptions VolumeAAPGAscentage Pharma Group InternationalN/A$43.48-9.2%N/AN/A$4.45B$134.35M0.00600Positive NewsHigh Trading VolumeKRYSKrystal Biotech4.8124 of 5 stars$146.77-2.5%$210.38+43.3%-19.6%$4.36B$290.52M29.83210Positive NewsACADACADIA Pharmaceuticals4.0432 of 5 stars$25.32-1.6%$28.88+14.0%+57.2%$4.34B$957.80M19.04510Analyst RevisionADMAADMA Biologics3.9279 of 5 stars$17.01-4.4%$27.67+62.6%+2.0%$4.25B$426.45M19.78530Positive NewsTLXTelix PharmaceuticalsN/A$12.20-2.2%$22.33+83.1%N/A$4.22B$516.72M0.00N/AAnalyst RevisionGap DownPCVXVaxcyte2.7844 of 5 stars$30.45-5.7%$136.50+348.3%-70.9%$4.19BN/A-7.41160News CoveragePositive News Related Companies and Tools Related Companies Merus Alternatives CRISPR Therapeutics Alternatives TG Therapeutics Alternatives Cytokinetics Alternatives Ascentage Pharma Group International Alternatives Krystal Biotech Alternatives ACADIA Pharmaceuticals Alternatives ADMA Biologics Alternatives Telix Pharmaceuticals Alternatives Vaxcyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EVO) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Evotec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVO Stock Alerts